These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25124326)

  • 1. A novel variant in GABRB2 associated with intellectual disability and epilepsy.
    Srivastava S; Cohen J; Pevsner J; Aradhya S; McKnight D; Butler E; Johnston M; Fatemi A
    Am J Med Genet A; 2014 Nov; 164A(11):2914-21. PubMed ID: 25124326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.
    Ma DQ; Whitehead PL; Menold MM; Martin ER; Ashley-Koch AE; Mei H; Ritchie MD; Delong GR; Abramson RK; Wright HH; Cuccaro ML; Hussman JP; Gilbert JR; Pericak-Vance MA
    Am J Hum Genet; 2005 Sep; 77(3):377-88. PubMed ID: 16080114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the GABRB2-Associated Neurodevelopmental Disorders.
    El Achkar CM; Harrer M; Smith L; Kelly M; Iqbal S; Maljevic S; Niturad CE; Vissers LELM; Poduri A; Yang E; Lal D; Lerche H; Møller RS; Olson HE;
    Ann Neurol; 2021 Mar; 89(3):573-586. PubMed ID: 33325057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
    Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
    Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.
    Hernandez CC; XiangWei W; Hu N; Shen D; Shen W; Lagrange AH; Zhang Y; Dai L; Ding C; Sun Z; Hu J; Zhu H; Jiang Y; Macdonald RL
    Brain; 2019 Jul; 142(7):1938-1954. PubMed ID: 31056671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy.
    Hirose S
    Prog Brain Res; 2014; 213():55-85. PubMed ID: 25194483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABA
    Li PP; Zhou YY; Gao L; Lv JN; Xu SS; Zhao YW; Xu D; Huang R; Zhang X; Li P; Fu X; He Z
    Neuroscience; 2024 Aug; 553():172-184. PubMed ID: 38964454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations in GABA metabolism and epilepsy.
    Feng Y; Wei ZH; Liu C; Li GY; Qiao XZ; Gan YJ; Zhang CC; Deng YC
    Seizure; 2022 Oct; 101():22-29. PubMed ID: 35850019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical descriptions of patients with GABA
    Maillard PY; Baer S; Schaefer É; Desnous B; Villeneuve N; Lépine A; Fabre A; Lacoste C; El Chehadeh S; Piton A; Porter LF; Perriard C; Wardé MA; Spitz MA; Laugel V; Lesca G; Putoux A; Ville D; Mignot C; Héron D; Nabbout R; Barcia G; Rio M; Roubertie A; Meyer P; Paquis-Flucklinger V; Patat O; Lefranc J; Gerard M; ; de Bellescize J; Villard L; De Saint Martin A; Milh M
    Epilepsia; 2022 Oct; 63(10):2519-2533. PubMed ID: 35718920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
    Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
    Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association study in the Taiwan Biobank elicits the GABAA receptor genes GABRB3, GABRA5, and GABRG3 as candidate loci for sleep duration in the Taiwanese population.
    Hou SJ; Tsai SJ; Kuo PH; Lin WY; Liu YL; Yang AC; Lin E; Lan TH
    BMC Med Genomics; 2021 Sep; 14(1):223. PubMed ID: 34530807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A
    Ishii A; Kang JQ; Schornak CC; Hernandez CC; Shen W; Watkins JC; Macdonald RL; Hirose S
    J Med Genet; 2017 Mar; 54(3):202-211. PubMed ID: 27789573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel EIF2S3 mutations associated with syndromic intellectual disability with severe microcephaly, growth retardation, and epilepsy.
    Moortgat S; Désir J; Benoit V; Boulanger S; Pendeville H; Nassogne MC; Lederer D; Maystadt I
    Am J Med Genet A; 2016 Nov; 170(11):2927-2933. PubMed ID: 27333055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population.
    Hernandez CC; Klassen TL; Jackson LG; Gurba K; Hu N; Noebels JL; Macdonald RL
    PLoS One; 2016; 11(9):e0162883. PubMed ID: 27622563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dravet syndrome-associated mutations in
    Hernandez CC; Tian X; Hu N; Shen W; Catron MA; Yang Y; Chen J; Jiang Y; Zhang Y; Macdonald RL
    Brain Commun; 2021; 3(2):fcab033. PubMed ID: 34095830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants.
    Mohammadi NA; Ahring PK; Yu Liao VW; Chua HC; Ortiz de la Rosa S; Johannesen KM; Michaeli-Yossef Y; Vincent-Devulder A; Meridda C; Bruel AL; Rossi A; Patel C; Klepper J; Bonanni P; Minghetti S; Trivisano M; Specchio N; Amor D; Auvin S; Baer S; Meyer P; Milh M; Salpietro V; Maroofian R; Lemke JR; Weckhuysen S; Christophersen P; Rubboli G; Chebib M; Jensen AA; Absalom NL; Møller RS
    EBioMedicine; 2024 Aug; 106():105236. PubMed ID: 38996765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.
    Ahring PK; Liao VWY; Gardella E; Johannesen KM; Krey I; Selmer KK; Stadheim BF; Davis H; Peinhardt C; Koko M; Coorg RK; Syrbe S; Bertsche A; Santiago-Sim T; Diemer T; Fenger CD; Platzer K; Eichler EE; Lerche H; Lemke JR; Chebib M; Møller RS
    Brain; 2022 May; 145(4):1299-1309. PubMed ID: 34633442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype.
    Vogel FD; Krenn M; Westphal DS; Graf E; Wagner M; Leiz S; Koniuszewski F; Augé-Stock M; Kramer G; Scholze P; Ernst M
    Epilepsia; 2022 Apr; 63(4):e35-e41. PubMed ID: 35152403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
    Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
    J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA
    Agrawal J; Dwivedi Y
    Front Neurosci; 2020; 14():600099. PubMed ID: 33240041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.